Skip to content

Correlation Between Optic Nerve Vessel Anomalies, Serum Angiogenic Factors and Renal Anomalies in Down Syndrome Children

Interventional Controlled Cross-sectional Study Assessing the Correlation Between Optic Nerve Vessels Anomalies, Serum Angiogenic Factors and Renal Anomalies in Children With Down Syndrome.

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03206957
Acronym
DOPANUR
Enrollment
200
Registered
2017-07-02
Start date
2017-11-30
Completion date
2019-06-01
Last updated
2018-07-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Down Syndrome

Brief summary

In approximately half of individuals with Down syndrome, an higher than normal number of vessels cross the optic disc margin. Investigator hypothesize that early retinal vessel branching occurs due to inhibition of angiogenesis by triplet overexpression of endostatin, an angiogenesis inhibitor encoded on chromosome 21. Since angiogenesis is critical in the development of eyes and other organs angiogenesis depended (specially kidney, brain, and recently described lungs and heart), early branching of retinal vessels at the level of the optic disc would also likely result in abnormal renal and other organs development in these individuals. Investigator wish to determine whether observation of optic disc vessels may serve as an indicator of elevated endostatin levels and other angiogenesis-dependent organs anomalies.

Detailed description

Investigator will measure the serum levels of endostatin as well as others angiogenetic factors in Down syndrome children versus control group 1 constituted by the patient mothers. Investigator will also perform renal and low urinary tract Doppler ultrasound with measurement of renal dimension in order to determine if the kidneys of patients with high level of serum of endostatin are smaller than those of patients with normal level of endostatin. Data observed in Down syndrome children will be compared to control group 2age constituted by sex and age matched healthy children Urine microalbuminuria and urine microalbuminuria/creatinuria from the first urine in the morning will be evaluated.

Interventions

DIAGNOSTIC_TESTFunduscopic examination and retinal photography

A standardized funduscopic examination and retinal photography will be performed by an ophthalmologist focusing on optic nerve.

DIAGNOSTIC_TESTSerum levels of endostatin and angiogenesis factors

Serum levels of endostatin, angiopoietin and vaso endothelial growth factor will be analyzed

DIAGNOSTIC_TESTRenal and low urinary tract Doppler ultrasound

Measurements of each kidney will include maximum renal bipolar length in a sagittal plane, renal width and thickness in an axial plane perpendicular to each other at the level of renal hilum and cortical thickness. Intensity of corticomedullary differentiation will estimated. Doppler ultrasound examination will assess renal arterial resistivity indexes

DIAGNOSTIC_TESTUrinalysis

Urinalysis assessments will include assessments of microalbuminuria and microalbuminuria to creatinuria ratio. A spot urine sample will be collected from first morning void.

DIAGNOSTIC_TESTAnthropometric measures and vitals signs

weight, height and blood pressure will be assessed

Sponsors

Queen Fabiola Children's University Hospital
Lead SponsorOTHER

Study design

Allocation
NON_RANDOMIZED
Intervention model
PARALLEL
Primary purpose
DIAGNOSTIC
Masking
NONE

Intervention model description

Interventional controlled cross-sectional study

Eligibility

Sex/Gender
ALL
Age
No minimum to 17 Years
Healthy volunteers
Yes

Inclusion criteria

* Provision of personally signed and dated informed consent document by adult subject or parents * When capable of providing assent, provision of personally signed and dated informed assent document by children * Subjects and/or their caregivers/parents are willing and able to comply with scheduled laboratory tests, and other required study procedures.

Exclusion criteria

• Inability to cooperate with study related examination For Study Group subjects * Known chronic diseases unrelated to their triallelic condition For Control Group n°1 & Control Group n°3 * General disease in which the level of endostatin may be modified such as leukemia, cancers, inflammatory diseases (e.g.: rheumatoid arthritis, Crohn's disease, psoriasis) * Any condition that may cause a hypoxia * Pregnancy For Control Group n°2: * Healthy children except benign ophthalmological refraction anomalies * Any known renal or low urinary tract diseases.

Design outcomes

Primary

MeasureTime frameDescription
Correlation between the number of retinal vessels crossing the optic disc and serum level of endostatin18 monthscorrelation coefficent

Secondary

MeasureTime frameDescription
Correlation between serum level of endostatin and serum level of other angiogenic factors18 monthscorrelation coefficient
Description of renal anomalies in Down syndrome.18 monthsabsolute number and type of renal anomalies
Correlation between the number of retinal vessels crossing the optic disc and serum level of other angiogenic factors18 monthscorrelation coefficent
Correlation between the number of optic nerve vessels and the presence of organs pathologies18 monthscorrelation coefficient
Correlation between serum level of angiogenesis factors and the presence of organs pathologies18 monthscorrelation coefficient
Comparison of prevalence of renal anomalies between Down syndrome and healthy subjects18 monthsProportion and type of disease

Countries

Belgium

Contacts

Primary ContactLavina Postolache, MD
lavina.postolache@huderf.be0032 2 477 21 92

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026